144 related articles for article (PubMed ID: 11561084)
1. Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.
Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2001 Oct; 299(1):227-37. PubMed ID: 11561084
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
[TBL] [Abstract][Full Text] [Related]
3. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
Angelova PR; Müller WS
Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
[TBL] [Abstract][Full Text] [Related]
5. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
Kurata HT; Wang Z; Fedida D
J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes).
Wang SJ; Wang KY; Wang WC
Neuroscience; 2004; 125(1):191-201. PubMed ID: 15051158
[TBL] [Abstract][Full Text] [Related]
7. Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Lamanauskas N; Nistri A
Eur J Neurosci; 2008 May; 27(10):2501-14. PubMed ID: 18445055
[TBL] [Abstract][Full Text] [Related]
8. Modulation of native TREK-1 and Kv1.4 K+ channels by polyunsaturated fatty acids and lysophospholipids.
Danthi S; Enyeart JA; Enyeart JJ
J Membr Biol; 2003 Oct; 195(3):147-64. PubMed ID: 14724761
[TBL] [Abstract][Full Text] [Related]
9. Interaction of high concentrations of riluzole with recombinant skeletal muscle sodium channels and adult-type nicotinic receptor channels.
Mohammadi B; Lang N; Dengler R; Bufler J
Muscle Nerve; 2002 Oct; 26(4):539-45. PubMed ID: 12362421
[TBL] [Abstract][Full Text] [Related]
10. Kv1.2-containing K+ channels regulate subthreshold excitability of striatal medium spiny neurons.
Shen W; Hernandez-Lopez S; Tkatch T; Held JE; Surmeier DJ
J Neurophysiol; 2004 Mar; 91(3):1337-49. PubMed ID: 13679409
[TBL] [Abstract][Full Text] [Related]
11. HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells.
Chao CC; Shieh J; Kuo SC; Wu BT; Hour MJ; Leung YM
Neuropharmacology; 2008 Jun; 54(7):1128-35. PubMed ID: 18406431
[TBL] [Abstract][Full Text] [Related]
12. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
Zhang HX; Zhang W; Jin HW; Wang XL
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):136-40. PubMed ID: 15530663
[TBL] [Abstract][Full Text] [Related]
13. Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p-aminobenzoate, a promising anesthetic for the treatment of chronic pain.
Beekwilder JP; O'Leary ME; van den Broek LP; van Kempen GT; Ypey DL; van den Berg RJ
J Pharmacol Exp Ther; 2003 Feb; 304(2):531-8. PubMed ID: 12538804
[TBL] [Abstract][Full Text] [Related]
14. State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes.
Iftinca M; Waldron GJ; Triggle CR; Cole WC
J Pharmacol Exp Ther; 2001 Aug; 298(2):718-28. PubMed ID: 11454936
[TBL] [Abstract][Full Text] [Related]
15. The modulatory effect of zinc ions on voltage-gated potassium currents in cultured rat hippocampal neurons is not related to Kv1.3 channels.
Teisseyre A; Mercik K; Mozrzymas JW
J Physiol Pharmacol; 2007 Dec; 58(4):699-715. PubMed ID: 18195482
[TBL] [Abstract][Full Text] [Related]
16. Concatemers of brain Kv1 channel alpha subunits that give similar K+ currents yield pharmacologically distinguishable heteromers.
Sokolov MV; Shamotienko O; Dhochartaigh SN; Sack JT; Dolly JO
Neuropharmacology; 2007 Aug; 53(2):272-82. PubMed ID: 17637465
[TBL] [Abstract][Full Text] [Related]
17. Expression of voltage-gated K+ channels in human atrium.
Bertaso F; Sharpe CC; Hendry BM; James AF
Basic Res Cardiol; 2002 Nov; 97(6):424-33. PubMed ID: 12395204
[TBL] [Abstract][Full Text] [Related]
18. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
Castle NA; Fadous SR; Logothetis DE; Wang GK
Mol Pharmacol; 1994 Dec; 46(6):1175-81. PubMed ID: 7808439
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of copper ions on lymphocyte Kv1.3 potassium channels.
Teisseyre A; Mozrzymas JW
J Physiol Pharmacol; 2006 Jun; 57(2):301-14. PubMed ID: 16845233
[TBL] [Abstract][Full Text] [Related]
20. Effects of various K+ channel blockers on spontaneous glycine release at rat spinal neurons.
Shoudai K; Nonaka K; Maeda M; Wang ZM; Jeong HJ; Higashi H; Murayama N; Akaike N
Brain Res; 2007 Jul; 1157():11-22. PubMed ID: 17555723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
